Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001389319 | SCV001590641 | pathogenic | Cerebral creatine deficiency syndrome | 2024-07-22 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Gln97*) in the GAMT gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in GAMT are known to be pathogenic (PMID: 15108290). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with GAMT deficiency (PMID: 23234264). ClinVar contains an entry for this variant (Variation ID: 1075655). For these reasons, this variant has been classified as Pathogenic. |
Baylor Genetics | RCV003469756 | SCV004198600 | pathogenic | Deficiency of guanidinoacetate methyltransferase | 2023-11-08 | criteria provided, single submitter | clinical testing |